Bya Cocer Peptides 
ennaku 13 eziyise
EBINTU BYONNNA N’AMAWULIRE GW’EBINTU EBIweereddwa KU MUTINDO GUNO BIKOZESEBWA KU KUSASANYA AMAWULIRE N’EBIKOLWA BY’OKUSOMESA.
Ebintu ebiweereddwa ku mukutu guno bigendereddwamu kunoonyereza mu kisenge (in vitro research) byokka. Okunoonyereza mu vitro (Olulattini: *mu ndabirwamu*, ekitegeeza mu bikozesebwa mu ndabirwamu) kukolebwa ebweru w’omubiri gw’omuntu. Ebintu bino si bya ddagala, tebikkiriziddwa kitongole kya Amerika ekivunaanyizibwa ku by’emmere n’eddagala (FDA), era tebirina kukozesebwa kuziyiza, kujjanjaba oba kuwonya mbeera yonna ya bujjanjabi, bulwadde oba bulwadde. Kikugirwa nnyo mu mateeka okuyingiza ebintu bino mu mubiri gw’omuntu oba ebisolo mu ngeri yonna.
Omugejjo gweyongera okufuuka ensonga ey’amaanyi mu nsi yonna, nga tegukosa bulamu bwa mubiri gwokka wabula era gukwatagana nnyo n’endwadde ezitawona ng’endwadde z’emisuwa ne sukaali ow’ekika eky’okubiri. Okuzuula enkola ezitali za bulabe era ezikola obulungi ez’okugejja kibadde kikulu nnyo mu kunoonyereza kw’abasawo. Tizepatide ddagala erikola ku dual receptors, nga liwa enkola empya ey’okujjanjaba omugejjo.
Ekifaananyi 1: Enzimba n’emitendera egisooka egy’obubonero bwa molekyu okuyita mu GIPR ne GLP1R mu GIPR–GLP1R dual agonists RG7697–NNCOO90-2746 ne LY3298176.
Enkola ya Tizepatide eya Dual Receptor Agonist Mechanism
(1) Enkola ya GIP Receptor Agonist
Omusingi gw’omubiri (physiological Basis) ogwa GIP Receptor
GIP receptor ye cell receptor ey’enjawulo esangibwa mu bitundu ebingi, omuli pancreas, adipose tissue, ekibumba, n’ebinywa. Ku ngulu w’obutoffaali bwa β obw’ekizinga ky’olubuto, obusimu bwa GIP bwe bukwatagana ku kifo kino, bukola amakubo g’obubonero mu butoffaali, ekivaako okweyongera kw’emiwendo gya cAMP mu butoffaali. cAMP olwo ekola protein kinase A, nga eno, okuyita mu nkola eziddiriŋŋana, etumbula okufulumya insulini.
Mu bitundu by’amasavu, okukola kw’ekirungo kya GIP kulungamya enkyukakyuka y’obutoffaali bw’amasavu. Kitumbula okutwalibwa kwa glucose okuva mu adipocytes, kyongera ku fatty acid synthesis n’okutereka, era kiziyiza lipolysis. Okunoonyereza kulaga nti enkola eno eyinza okuba nga ekwatagana n’okweyongera kw’omuwendo gw’ebitambuza glucose (GLUT4), ebiyamba glucose okuyingira mu adipocytes, ne biwa ebintu ebisookerwako okukola amasavu.
Ebikolwa bya Tizepatide ku GIP Receptor
Tizepatide erina ensengekera efaananako n’obusimu bwa GIP era esobola okwesiba mu ngeri ey’enjawulo n’okukola ku bikwata GIP. Bw’ogeraageranya ne GIP ey’omunda, Tizepatide erina enkolagana ey’amaanyi ey’okusiba ku bikwata, okusobozesa okukola obulungi amakubo g’obubonero. Okunoonyereza kulaga nti oluvannyuma lw’okusiba ku bikwata, kisobola okwongera ku miwendo gya cAMP mu ngeri ey’obwegendereza, bwe kityo ne kitumbula nnyo okufulumya insulini. Mu bitundu by’amasavu, okulungamya kwayo okutuufu okw’enkyukakyuka y’amasavu oluvannyuma lw’okukola kw’amasavu kusobozesa byombi okutwalibwa kwa glucose obutoffaali bw’amasavu n’okusengejja n’okutereka asidi z’amasavu mu ngeri ey’enjawulo, okuziyiza okukuŋŋaanyizibwa kw’amasavu okuyitiridde —ensonga enkulu mu kukuuma enkyukakyuka y’amasavu eya bulijjo.
Ekifaananyi 2: Ebikolwa eby’okugeraageranya ebya RG7697/NNCOO90-2746 ne LY3298176 okuva mu kugezesebwa okw’obujjanjabi, okuggyako awali emmunyeenye eziraga (eziragiddwa mu biwuka byokka).
(2) Enkola y’okukola kwa GLP-1 Receptor
Omusingi gw’omubiri gwa GLP-1 Receptors
GLP-1 receptor era ye cell receptor esinga kusaasaanyizibwa mu butoffaali bwa β obw’olubuto, enkola y’olubuto n’obwongo. Mu butoffaali bwa β obw’olubuto, GLP-1 yeekwata ku kisengejja era n’ekola amakubo g’obubonero okutumbula okufulumya insulini. Okwawukanako ne GIP, ebikolwa bya GLP-1 bifugibwa emiwendo gya glucose mu musaayi: kitumbula okufulumya insulini nga glucose mu musaayi mungi ate ebikolwa byayo binafuwa nga glucose mu musaayi ali wa bulijjo, ekigifuula ey’obukuumi.
Mu nkola y’omu lubuto, okukola kw’ekirungo kya GLP-1 kwongera okusigala kw’emmere mu lubuto, ne kiziyiza glucose okulinnya amangu mu musaayi oluvannyuma lw’okulya, era n’okuziyiza okufulumya asidi mu lubuto, ne kikuuma omubiri gw’omu lubuto. Mu bwongo, kikola ku bitundu ebifuga okwagala okulya, okukendeeza enjala n’okwongera okukkuta, bwe kityo ne kivaako okukendeeza ku mmere.
Ebikolwa bya Tizepatide ku GLP-1 receptor
Tizepatide erina enkolagana ey’amaanyi ey’okusiba ku GLP-1 receptors, era ku activation, ekola ebikolwa ebifaananako n’ebya endogenous GLP-1. Mu nsonga y’okulungamya glucose mu musaayi, kitumbula okufulumya insulini okusinziira ku glucose mu musaayi, bwe kityo ne kifuga bulungi glucose mu musaayi. Mu nkola y’olubuto, ekikolwa kyayo eky’okulwawo okufulumya amazzi mu lubuto kyeyoleka nnyo okusinga eky’eddagala erimu ery’ekinnansi. Mu bwongo, ekikolwa kyayo ekiziyiza okwagala okulya kiwangaala nnyo, era kiyamba bulungi okugejja.
(3) Ebikolwa eby’okukwatagana eby’obusimu bwa Dual Receptor Agonism
Ebikosa Ebikwatagana mu Kulungamya Glucose mu Musaayi
Tizepatide ekola ku GIP ne GLP-1 receptors zombi, ekivaamu okulungamya obulungi glucose mu musaayi. GIP okusinga etumbula mangu okufulumya insulini mu kiseera ekisooka oluvannyuma lw’okulya, okukendeeza ku ntikko za glucose mu musaayi; GLP-1 egenda mu maaso n’okukola mu nkola yonna ey’oluvannyuma lw’okulya, si kutumbula kufulumya insulini yokka wabula n’okulwawo okufulumya amazzi mu lubuto, okukendeeza ku mmere gye balya, n’okukuuma emiwendo gya glucose mu musaayi nga tekyukakyuka. Okukola ebikwata ku bitundu byombi omulundi gumu kivaamu okufuga obulungi glucose mu musaayi oluvannyuma lw’okulya. Okugeza, mu kugezesa ebisolo ebya ssukaali, Tizepatide yakendeeza ku kweyongera kwa glucose mu musaayi oluvannyuma lw’okulya okusinga eddagala lya GIP oba GLP-1 lyokka, era glucose mu musaayi n’adda mu mbeera eya bulijjo amangu.
Ebikosa Enkolagana ku Nkyukakyuka y’Amaaso
Mu nsonga y’okukyusakyusa amaanyi, GIP receptor agonists zitumbula okutwalibwa kwa glucose obutoffaali bw’amasavu, naye wansi w’okufugibwa Tizepatide, okusengejja amasavu tekukung’aanyizibwa nnyo. Mu kiseera kino, GLP-1 receptor agonists ziziyiza okwagala okulya, zongera okukkuta, zikendeeza ku kalori z’olya, era zitumbula okwokya amasavu n’okukozesa amaanyi. Ekikolwa kino eky’emirundi ebiri kigerageranya amaanyi agayingira n’ensaasaanya. Okugeza, mu kugezesa ebisolo ebinene ennyo, oluvannyuma lw’okukozesa Tizepatide okumala ekiseera, obuzito bw’omubiri gw’ebisolo bwakendeera, amasavu mu mubiri ne gakendeera, era metabolism ya basal yayanguwa.
Ekifaananyi 3: Enjawulo wakati wa synergistic agonists (chimeras) n’ensengekera z’okuyungibwa kwa peptide
Okusiiga eddagala lya Tizepatide mu kujjanjaba omugejjo
(1) Ebiva mu kugejja
Obujulizi bw’okunoonyereza nga tekunnabaawo
Mu kugezesa ebisolo, ebibe ebinene ennyo ebyaweebwa Tizepatide byalaga okugejja mpolampola okumala ekiseera, nga bikendedde nnyo bw’ogeraageranya n’ekibinja ekifuga. Okwekenenya amasavu mu mubiri kwalaga nti tegakoma ku kukendeeza masavu wabula n’okulongoosa ensaasaanya y’amasavu, ne gakendeeza ku kukuŋŋaanyizibwa kw’amasavu mu bitundu by’omubiri. Enkola ezisookerwako zirina emirundi ebiri: ekisooka, okukola kw’ekirungo kya GLP-1 kunyigiriza okwagala okulya nga kiziyiza ekifo ky’obwongo enjala; ekyokubiri, kitumbula okwokya amasavu n’okwongera ku nsaasaanya y’amaanyi.
Obujulizi obw’okugezesebwa mu malwaliro
Mu kugezesebwa okw’obujjanjabi okwagenderera abalwadde abagejjulukuka, Tizepatide era yalaga nti ekola bulungi mu kugejja. Okugezesebwa okungi okwakolebwa mu ngeri ey’ekifuulannenge (multiple randomized controlled trials) kwalaga nti oluvannyuma lw’ekiseera nga bajjanjabwa, obuzito bw’omubiri gw’abalwadde bwakendeera nnyo. Okugeza, mu kugezesebwa okwamala wiiki 24, ekibinja ky’abajjanjabi kyafuna okugejja kwa wakati nga 10%, ate ekibinja kya placebo kyalaga enkyukakyuka ntono. Okugatta ku ekyo, ekiwato ky’abalwadde n’ekisambi nabyo byakendeera, ekiraga nti tekikoma ku kutumbula kugejja wabula kiyamba n’okusaasaanya amasavu n’okukendeeza ku bulabe bw’endwadde ezeekuusa ku mugejjo.
(2) Okulongoosa ebiraga ebikwatagana n’obulwadde bw’enkyukakyuka mu mubiri
Okulongoosa mu nkola ya Glucose mu musaayi
Abalwadde abagejjulukuka batera okuba n’ensonga za glucose mu musaayi, era Tizepatide alongoosa okufuga glucose mu musaayi ate nga atumbula okugejja. Mu kugezesebwa mu malwaliro, abalwadde baafuna okukendeera okw’amaanyi mu glucose mu musaayi mu kisiibo, glucose mu musaayi oluvannyuma lw’okulya, ne hemoglobin A1c (ekiraga okufuga glucose mu musaayi okumala ebbanga eddene) oluvannyuma lw’okujjanjabwa. Kino kiri bwe kityo kubanga kikola okuyita mu nkola za dual receptor mechanisms, okutumbula okufulumya insulini n’okutumbula okuwulira insulin, ate nga era kilwawo okufulumya emmere mu lubuto n’okukendeeza ku kunywa amangu emmere. Bw’ogeraageranya n’eddagala ly’ekinnansi eriweweeza ku ssukaali, terikoma ku kukendeeza ku sukaali mu musaayi wabula litumbula n’okugejja, ne liwa emigaso mingi eri abalwadde abagejjulukuka abalina ssukaali.
Okulongoosa mu kulungamya amasavu
Omugejjo gutera okuwerekerwako obuzibu bw’amasavu mu musaayi, gamba ng’obungi bwa triglycerides n’obungi bwa high-density lipoprotein (HDL) obutono. Tizepatide esobola okutereeza amasavu: oluvannyuma lw’okugiwa, abalwadde baafuna okukendeera kw’emiwendo gya triglyceride n’okweyongera kw’emiwendo gya HDL. Kino kiyinza okuba nga kyekuusa ku kulungamya kwayo mu nkyukakyuka y’amasavu, gamba ng’okutumbula okutwalibwa kwa glucose obutoffaali bw’amasavu, okukendeeza ku kufulumya asidi w’amasavu, n’okutumbula oxidation y’amasavu, bwe kityo n’elongoosa ebifaananyi by’amasavu n’okukendeeza ku bulabe bw’endwadde z’emisuwa.
(3) Emigaso egiyinza okuva mu nkola y’emisuwa gy’omutima
Okutereeza puleesa
Omugejjo kye kimu ku bintu ebiyinza okuvaako puleesa. Okunoonyereza mu bujjanjabi kuzudde nti oluvannyuma lw’okujjanjabwa eddagala lya Tizepatide, puleesa y’abalwadde ey’omusaayi (systolic and diastolic blood pressure) zombi zikendeera. Kino kiyinza okuba nga kyekuusa ku kugejja n’okulongoosa mu nkyukakyuka y’emmere: okugejja kikendeeza ku buzito ku mutima, era okulongoosa mu musaayi n’amasavu biyamba okuzzaawo obulamu bw’emisuwa n’okukendeeza ku buziyiza bw’emisuwa. Okugatta ku ekyo, ebikolwa byayo ku nkola y’olubuto n’ekyenda biyinza okukosa mu ngeri etali butereevu ku nkola y’obusimu obukola omubiri, bwe kityo ne kitereeza puleesa.
Ebikolwa by’okukuuma emisuwa
Okuzimba okutambula obutasalako n’okunyigirizibwa kw’okwokya (oxidative stress) bitera okubeera mu balwadde abagejjulukuka, ekiyinza okwonoona endothelium y’emisuwa n’okutumbula okuzimba emisuwa. Tizepatide ekuuma endothelium y’emisuwa ng’etereeza enkyukakyuka mu mubiri, okukendeeza ku kufulumya ebintu ebizimba, n’okukendeeza ku situleesi y’okwokya. Okunoonyereza kulaga nti oluvannyuma lw’okujjanjabwa, obubonero bw’okuzimba abalwadde nga C-reactive protein (CRP) bwakendeera, era ebiraga enkola y’emisuwa ng’okufulumya nitric oxide byeyongera, ekiraga nti obulamu bw’emisuwa bwalongooka n’okuyamba mu kuziyiza endwadde z’emisuwa.
Mu bufunzi
Tizepatide eraga obusobozi obw’amaanyi mu kujjanjaba omugejjo ng’ekola mu kiseera kye kimu ku bikwata GIP ne GLP-1. Tekoma ku kutumbula bulungi kugejja wabula era erongoosa ebiraga enkyukakyuka mu mubiri nga glucose mu musaayi n’amasavu, ate nga kiwa obukuumi bw’emisuwa. Okuyita mu nkola zaayo ez’enjawulo ez’okukola, egaba enkola empya ey’obujjanjabi eri omugejjo n’embeera ezikwatagana nabyo.
Ensonda
[1] Boer GA, Hay DL, Tups A. Eddagala ly’omugejjo: ekikolwa kya incretin mu nkola y’obusimu obw’omu makkati[J]. Emitendera mu Sayansi w’Eddagala, 2023,44 (1): 50-63.DOI: 10.1016 / j.tips.2022.11.001.
[2] Jensen T. L., Nden ABO, Karstoft K., n’abalala. Tirzepatid, eddagala eriyitibwa Tirzepatid. Dual GLP-1/GIP receptor agonist, Obujjanjabi bwa sukaali ow’ekika eky’okubiri n’omugejjo[J]. Eddagala ly’omu maaso, 2023. DOI:10.3389/fendo.2022.1004044
[3] Willard F. S., Douros J. D., Gabe M. B., n’abalala. Tirzepatid ye ddagala eritali lya bbalansi era eririna obusosoze erya dual GIP ne GLP-1 receptor agonist[J]. Jci Okutegeera, 2020,5 (17).DOI: 10.1172 / jci.okutegeera.140532.
[4] Bastin M, Andreelli F. Dual GIP-GLP1-Receptor Agonists Mu Bujjanjabi Bwa Ssukaali ow'Ekika 2: Okwekkaanya Okumpi Ku Data Emering N'obusobozi Obujjanjabi[J]. Ssukaali Metabolic Syndrome n'omugejjo-Ebigendererwa n'obujjanjabi, 2019,12:1973-1985.DOI: 10.2147 / DMSO.S191438.
Ekintu ekiriwo okukozesebwa mu kunoonyereza kwokka:
